scispace - formally typeset
P

Pierre Renard

Researcher at University of Caen Lower Normandy

Publications -  154
Citations -  4362

Pierre Renard is an academic researcher from University of Caen Lower Normandy. The author has contributed to research in topics: Melatonin & Receptor. The author has an hindex of 34, co-authored 154 publications receiving 4150 citations. Previous affiliations of Pierre Renard include Blaise Pascal University & Paul Sabatier University.

Papers
More filters
Journal ArticleDOI

Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.

TL;DR: Quaternary ammonium conjugates of tetracyclines synthesized by direct alkylation of the amine function at the 4-position with methyl iodide inhibited cytokine-induced MMP expression to a lesser extent and could be potent drug candidates for cartilage- targeting chondroprotective treatment.
Journal ArticleDOI

Synthesis of 3-phenylnaphthalenic derivatives as new selective MT2 melatoninergic ligands

TL;DR: N-[2-(3-hydroxymethylphenyl)-7-methoxynaphth-1-yl)ethyl]acetamide (21) is one of the best MT(2) selective ligands described until now and behaves as an antagonist.
Journal ArticleDOI

Regulation of emotional behaviour by day length in mice: implication of melatonin.

TL;DR: Evidence is provided that the modulation of circulating melatonin could be involved in the emotional changes related to day-length variations, and whether pinealectomy could counteract the photoperiod-related changes in anxiety.
Journal ArticleDOI

Synthesis and pharmacology of pyrid-3-yl sulfonylureas and thioureas as astrocytic Na+ 2Cl- K+ cotransporter inhibitors

TL;DR: The pharmacology of lipophilic 4-arylamino- and 4-cycloalkylaminopyrid-3-ylsulfonyl(thio)ureas and their synthesis designed from torasemide could lead to a method of inhibiting the astrocytic Na+ 2C1− K+ cotransporter and thus treating cerebral edema.
Journal ArticleDOI

Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3

TL;DR: Benzofuranic analogues of MCA-NAT (5-methoxycarbonylamino-N-acetyltryptamine) have been synthesized and evaluated as melatonin receptor ligands and introduction of a methoxycarbonic substituent in the C-5 position of the benzofurane nucleus obtains MT(3) selective ligands.